drug · antibody
bepranemab
Phase 2updated 3mo agoby UCB SA🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 2 (across all indications), with 2 investigational indications.
indications
indications
Alzheimer's Disease
targets
Microtubule-associated protein tau
all catalysts(0)
nothing on the calendar yet
Trials studying bepranemab
- phase1A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy
- phase2A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)
- phase1A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that